Transforming Growth Factor-β1 Expression and the Role of Angiotensin-converting Enzyme Inhibitor on Perianastomotic Intimal Hyperplasia in Polytetrafluoroethylene Graft Implanted in Rabbit Carotid Artery

Kurume Medical Journal

Volumn 51, Issue 42433, 2004, Pages 235-243

  Um, Jun Won ^a   Kim, Jong Man ^a   Min, Byung Wook ^a   Kim, Young Sik ^a   Son, Gil Soo ^a   Lee, Jae Bok ^a   Jung, Suk In ^a   Kim, Seung Joo ^a   Choi, Sang Yong ^a   Koo, Bum Hwan ^a   Ishibashi, Nobuya ^a,b   Shirouzu, Kazuo ^a,b   Whang, Chung Wung ^a  

^a Korea University College of Medicine   (South Korea)

^b KURUME UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

angiotensin converting enzyme inhibitors; carotid arteries; polytetrafluoroethylene; rabbits; transforming growth factor beta; tunica intima

Indexed keywords

CAPTOPRIL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; MESSENGER RNA; TRANSFORMING GROWTH FACTOR BETA1;

ANIMAL TISSUE; ARTERY ANASTOMOSIS; ARTERY BYPASS; ARTERY INTIMA; ARTERY INTIMA PROLIFERATION; ARTERY MEDIA; ARTICLE; CAROTID ARTERY; COMMON CAROTID ARTERY; CONTROLLED STUDY; DRUG EFFECT; GENE EXPRESSION; INTIMA TO MEDIA HEIGHT RATIO; MEASUREMENT; NONHUMAN; PERIANASTOMOTIC INTIMA HYPERPLASIA; POLITEF IMPLANT; RABBIT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TIME;

ANASTOMOSIS, SURGICAL; ANGIOTENSIN II; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; ANIMALS; BLOOD VESSEL PROSTHESIS IMPLANTATION; CAPTOPRIL; CAROTID ARTERY, COMMON; HYPERPLASIA; POLYTETRAFLUOROETHYLENE; RABBITS; RNA, MESSENGER; TIME FACTORS; TRANSFORMING GROWTH FACTOR BETA; TRANSFORMING GROWTH FACTOR BETA1; TUNICA INTIMA;

EID: 13444306547     PISSN: 00235679     EISSN: 18812090     Source Type: Journal    
DOI: 10.2739/kurumemedj.51.235     Document Type: Article

References (40)

1. Berkowitz H.D., Greenstein S., Barker C.F., and Perloff L.J. Late failure of reversed vein bypass grafts. Ann Surg 1989; 210:782-786.
2. Schoen F.J., and Castellot J.J., Jr. Vascular graft intimal fibrous hyperplasia: prospects for pharmacological inhibition. J Vasc Surg 1991; 13:758-761.
3. Clowes A.W., Kirkman T.R., and Reidy M.A. Mechanisms of arterial graft healing. Rapid transmural capillary ingrowth provides a source of intimal endothelium and smooth muscle in porous PTFE prostheses. Am J Pathol 1986; 123:220-230.
4. Oliver J.A., and Sciacca R.R. Local generation of angiotensin II as a mechanism of regulation of peripheral vascular tone in the rat. J Clin Invest 1984; 74:1247-1251.
5. Dzau V.J. Vascular renin-angiotensin: a possible autocrine or paracrine system in control of vascular function. J Cardiovasc Pharmacol 1984; 6:S377-S382.
6. Osterrieder W., Muller R.K., Powell J.S., Clozel J.P., Hefti F. et al. Role of angiotensin II in injury-induced neointima formation in rats. Hypertension 1991; 18:1160-1164.
7. Naftilan A.J., Pratt R.E., Eldridge C.S., Lin H.L., and Dzau V.J. Angiotensin II induces c-fos expression in smooth muscle via transcriptional control. Hypertension 1989; 13:706-711.
8. Itoh H., Mukoyama M., Pratt R.E., Gibbons G.H., and Dzau V.J. Multiple autocrine growth factors modulate vascular smooth muscle cell growth response to angiotensin II. J Clin Invest 1993; 91:2268-2274.
9. Ross R., Raines E.W., and Bowen-Pope D.F. The biology of platelet-derived growth factor. Cell 1986; 46:155-169.
10. Golden M.A., Au Y.P., Kirkman T.R., Wilcox J.N., Raines E.W. et al. Platelet-derived growth factor activity and mRNA expression in healing vascular grafts in baboons. Association in vivo of platelet-derived growth factor mRNA and protein with cellular proliferation. J Clin Invest 1991; 87:406-414.
11. Zacharias R.K., Kirkman T.R., Kenagy R.D., Bowen-Pope D.F., and Clowes A.W. Growth factor production by poly-tetrafluoroethylene vascular grafts. J Vasc Surg 1988; 7:606-610.
12. Gibbons G.H., Pratt R.E., and Dzau V.J. Vascular smooth muscle cell hypertrophy vs. hyperplasia. Autocrine transforming growth factor-beta 1 expression determines growth response to angiotensin II. J Clin Invest 1992; 90:456-461.
13. Rasmussen L.M., Wolf Y.G., and Ruoslahti E. Vascular smooth muscle cells from injured rat aortas display elevated matrix production associated with transforming growth factor-beta activity. Am J Pathol 1995; 147:1041-1048.
14. Clowes A.W., and Reidy M.A. Mechanisms of arterial graft failure: the role of cellular proliferation. Ann NY Acad Sci 1987;516:673-678.
15. Ju H., and Dixon I.M. Extracellular matrix and cardiovascular diseases. Can J Cardiol 1996; 12:1259-1267.
16. Golden M.A., Au Y.P., Kenagy R.D., and Clowes A.W. Growth factor gene expression by intimal cells in healing polytetrafluoroethylene grafts. J Vasc Surg 1990; 11:580-585.
17. Gibbons G.H., and Dzau V.J. The emerging concept of vascular remodeling. N Engl J Med 1994; 330:1431-1438.
18. Border W.A., and Noble N.A. Transforming growth factor beta in tissue fibrosis. N Engl J Med 1994; 331:1286-1292.
19. Wolf Y.G., Rasmussen L.M., and Ruoslahti E. Antibodies against transforming growth factor-beta 1 suppress intimal hyperplasia in a rat model. J Clin Invest 1994; 93:1172-1178.
20. Hoch J.R., Stark V.K., and Turnipseed W.D. The temporal relationship between the development of vein graft intimal hyperplasia and growth factor gene expression. J Vasc Surg 1995; 22:51-58.
21. Rosenthal J.H., Pfeifle B., Michailov M.L., Pschorr J., Jacob I.C. et al. Investigations of components of the renin-angiotensin system in rat vascular tissue. Hypertension 1984; 6:383-390.
22. Dzau V.J. Implications of local angiotensin production in cardiovascular physiology and pharmacology. Am J Cardiol 1987; 59:59A-65A.
23. Morishita R., Gibbons G.H., Ellison K.E., Lee W., Zhang L. et al. Evidence for direct local effect of angiotensin in vascular hypertrophy. In vivo gene transfer of angiotensin converting enzyme. J Clin Invest 1994; 94:978-984.
24. Powell J.S., Clozel J.P., Muller R.K., Kuhn H., Hefti F. et al. Inhibitors of angiotensin-converting enzyme prevent myointimal proliferation after vascular injury. Science 1989;245:186-188.
25. Mak I.T., Freedman A.M., Dickens B.F., and Weglicki W.B. Protective effects of sulfhydryl-containing angiotensin converting enzyme inhibitors against free radical injury in endothelial cells. Biochem Pharmacol 1990; 40:2169-2175.
26. Clozel J.P., Powell J.S., Kuhn H., Muller R.K., Hefti F. et al. Vascular protection with cilazapril. Drugs 1991; 41:62-67.
27. Chopra M., Scott N., McMurray J., McLay J., Bridges A. et al. Captopril: a free radical scavenger. Br J Clin Pharmacol 1989; 27:396-399.
28. Chobanian A.V., Haudenschild C.C., Nickerson C., and Drago R. Antiatherogenic effect of captopril in the Watanabe heritable hyperlipidemic rabbit. Hypertension 1990; 15:327-331.
29. Aberg G., and Ferrer P. Effects of captopril on atherosclerosis in cynomolgus monkeys. J Cardiovasc Pharmacol 1990; 15:S65-S72.
30. Meredith P.A., Elliott H.L., Donnelly R., and Reid J.L. Dose-response clarification in early drug development. J Hypertens Suppl 1991; 9:S356-S357.
31. O'Donohoe M.K., Schwartz L.B., Radic Z.S., Mikat E.M., McCann R.L. et al. Chronic ACE inhibition reduces intimal hyperplasia in experimental vein grafts. Ann Surg 1991; 214:727-732.
32. Ebner R., Chen R.H., Lawler S., Zioncheck T., and Derynck R. Determination of type I receptor specificity by the type II receptors for TGF-beta or activin. Science 1993; 262:900-902.
33. Geisterfer A.A., Peach M.J., and Owens G.K. Angiotensin II induces hypertrophy, not hyperplasia, of cultured rat aortic smooth muscle cells. Circ Res 1988; 62:749-756.
34. Sho M., Sho E., Singh T.M., Komatsu M., Sugita A. et al. Subnormal shear stress-induced intimal thickening requires medial smooth muscle cell proliferation and migration. Exp Mol Pathol 2002; 72:150-160.
35. Kubota K., Okazaki J., Louie O., Kent K.C., and Liu B. TGF-beta stimulates collagen (I) in vascular smooth muscle cells via a short element in the proximal collagen promoter. J Surg Res 2003; 109:43-50.
36. Xiao M., You W., Yuan Z., and Xu G. Mechanism of intimal hyperplasia of venous grafts after coronary artery bypass grafting, an experimental study. Zhonghua Yi Xue Za Zhi 2002; 82:1550-1552.
37. Ducasse E., Cosset J.M., Mazurier J., Eschwege F., Puppinck P. et al. High-dose external ionizing radiation prevents intimal hyperplasia and limits secretion of growth factors PDGF, bFGF, and TGF-β1. Experiments and results. J Mal Vasc 2003; 28:68-72.
38. Wolff R.A., Tomas J.J., Hullett D.A., Stark V.E., van Rooijen N. et al. Macrophage depletion reduces monocyte chemotactic protein-1 and transforming growth factor-beta 1 in healing rat vein grafts. J Vasc Surg 2004; 39:878-888.
39. Okumura K., Sone T., Kondo J., Tsuboi H., Mukawa H. et al. Quinapril prevents restenosis after coronary stenting in patients with angiotensin-converting enzyme D allele. Circ J 2002; 66:311-316.
40. Kim S., Izumi Y., Izumiya Y., Zhan Y., Taniguchi M. et al. Beneficial effects of combined blockade of ACE and ATl receptor on intimal hyperplasia in balloon-injured rat artery. Arterioscler Thromb Vasc Biol 2002; 22:1299-1304.